The Fed meets next week, but a commodities meltdown and earnings season are adding to concerns about global growth and may steal some of its thunder.» Read More
There has been a shift in the debate about gun ownership. Until now, the debate has mainly centered on the social or second amendment issues, the right to bear arms. Suddenly, the conversation has moved to include investor responsibility—the power of money.
The tragedy of Sandy Hook has sent the stocks of gun makers plummeting, even as consumers appear to be flocking to buy new firearms.
CNBC's Bertha Coombs reports Vanguard is a top holder in Smith & Wesson, and the firm is saying it cannot manage its funds to meet the "social concerns" of all shareholders.
Take a look at some of Tuesday's midday movers:
CNBC's Courtney Reagan reports Dick's Sporting Goods has suspended the sale of modern sporting rifles in all of its stores chainwide, and removed all guns from sale and from display in their store nearest to Newtown; and Dr. Tevi Troy, Hundson Institute senior fellow, weighs in on whether mental illness spending should be increased.
Should big institutions step up pressure on weapon makers, or stop funding them altogether? Dan Primack, Fortune senior editor, shares his opinions.
Cerberus announced it is selling Freedom Group and returning money to investors, reports CNBC's Mary Thompson.
While many special dividends have already been paid, Street.com has compiled a small collection of deals.
WASHINGTON-- Tennessee lawyer Brian Manookian says he never considered himself a gun enthusiast. He owns just one handgun and was raised in a gun-free home. An analysis by The Associated Press of data tracking the health of the gun industry shows that President Barack Obama has presided over a heyday for guns.
WASHINGTON-- President Barack Obama has presided over a heyday for the gun industry despite predictions by the National Rifle Association four years ago that he would be the "most anti-gun president in American history."
NEW YORK-- Benchmark Research believes the sell-off last week of shares in firearms manufacturers was overdone, and reiterated a buy recommendation on the stocks of the biggest producers.
U.S. stocks advanced on Wednesday after stronger-than-expected employment and service-sector data in the United States. But a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $41.60, up 177 pct.
U.S. stocks rose on Wednesday after stronger-than-expected employment and service-sector data in the United States, but a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $40.65, up 171 pct. **HEWLETT-PACKARD CO, $15.67, down 8.4 pct.
**SAREPTA THERAPEUTICS INC, $40.19, up 168 pct. **BIOLASE INC, $2.11, up 27 pct. The company said health regulators in Europe and the United States approved its laser device for use in soft tissue surgery, teeth whitening, and pain therapy.
Cramer makes the call on viewers' favorite stocks.
On Tuesday, I opened up my copy of The Wall Street Journal and staring back at me on the front page are the words “White House Efforts to Relax Gun Exports Face Resistance.” Let’s look at six companies that are likely to benefit.
Nearly 47 percent more women are shooting today than a decade ago, according to the National Sporting Goods Association, and a Gallup poll last year found 23 percent of American women now own at least one gun.
Stocks in the S&P 1,500 displaying unusual volume in Thursday's trading session.
Uncertainty in a presidential election year. Warriors returning from the battlefields. The comeback of the hunter. These are just some of the reasons that gun experts and advocates cite as reasons why firearms makers are ringing in 2012 like gangbusters.
As the gun industry gathers in Las Vegas this week, the sales outlook is positive—and that's partly because of the recent shooting spree in Tucson.